Cargando…
Prediagnostic Serum-25 Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort: Answer to a Short Comment [Response to Letter]
Autores principales: | Andreassen, Bettina K, Hektoen, Helga H, Axcrona, Karol, Langseth, Hilde, Stenehjem, Jo S, Robsahm, Trude E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599866/ https://www.ncbi.nlm.nih.gov/pubmed/34803404 http://dx.doi.org/10.2147/CLEP.S345565 |
Ejemplares similares
-
Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort
por: Hektoen, Helga H, et al.
Publicado: (2021) -
Vitamin D and Vitamin D‐binding protein and risk of bladder cancer: A nested case‐control study in the Norwegian Janus Serum Bank Cohort
por: Hektoen, Helga H., et al.
Publicado: (2021) -
Prediagnostic serum 25-hydroxyvitamin D and melanoma risk
por: Stenehjem, Jo S., et al.
Publicado: (2020) -
Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study
por: Gislefoss, Randi Elin, et al.
Publicado: (2018) -
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
por: Hektoen, Helga H., et al.
Publicado: (2020)